Results 101 to 110 of about 1,268 (176)

Efgartigimod as a potential alternative to intravenous immunoglobulin in Guillain-Barré syndrome: a retrospective study. [PDF]

Front Immunol
Liu C, Wang K, Zhang S, Gao N, Xu G, Qi F.   +5 more
europepmc   +1 more source

Preliminary observations on the efficacy of efgartigimod in anti-LGI1-associated autoimmune encephalitis. [PDF]

Ther Adv Neurol Disord
Zuo JW, Dai YY, Liu WJ, Zhang JY, Shao XQ, Wang Q, Lv RJ.   +6 more
europepmc   +1 more source

Case Report: Anti-LGI1 encephalitis during FcRn inhibition with efgartigimod for myasthenia gravis: implications for the limitations of IgG recycling blockade. [PDF]

Front Immunol
Komatsu Y, Eura N, Nishimori Y, Kakehi Y, Kiriyama T, Sugie K.   +5 more
europepmc   +1 more source

Efficacy and safety of efgartigimod in very-late-onset myasthenia gravis. [PDF]

Front Immunol
Zhao Y, Qu M, Rong X, Sun X, Wang L, Liu M, Sui J.   +6 more
europepmc   +1 more source

Severe Hypogammaglobulinemia (IgG) During Efgartigimod Therapy in Neurological Practice: A Real-World Case Series. [PDF]

Cureus
Espinosa PS, Preisler J, Motiño Villanueva A, Bellon MB, Hennekens CH.   +4 more
europepmc   +1 more source

Treatment of refractory pemphigus vulgaris with efgartigimod

JAAD Case Reports
Matthew Helm, Gracyn Allan, Brigid Deck, Galen Foulke   +3 more
openaire   +3 more sources

Real-world experience with efgartigimod in generalized myasthenia gravis: a single-center retrospective study in China. [PDF]

Front Immunol
Niu Z, Wang J, Ren J, Liu R, Guo J, Zhang N, Zheng Y, Hao H, Gao F, Jin H.   +9 more
europepmc   +1 more source

Efgartigimod as Rescue Therapy for PD-1 Inhibitor-Associated Myasthenia Gravis, Myocarditis, and Myositis (MMM) Syndrome: A 2-Case Report and Literature Review. [PDF]

Am J Case Rep
Liu ZH, Duan LM, Fang XZ, Jiang W, Sun SW, Shang Y, Huang CL, Yuan Y.   +7 more
europepmc   +1 more source

Efficacy and safety of efgartigimod in the treatment of impending myasthenic crisis. [PDF]

Front Immunol
Li N, Zhang Y, Liu L, Jin Y, Zhao L, Zhu S, Li Y, Ma B, Peng J, Yang J, Li Q, Yang X.   +11 more
europepmc   +1 more source

A prospective real-world study of efgartigimod in the treatment of chronic inflammatory demyelinating polyradiculoneuropathy. [PDF]

Front Immunol
Nie X, Huang G, Ma Y, Zhu G, Qi W, Zhou H, Wang W, Hao L, Guo X.   +8 more
europepmc   +1 more source